Search - tctmd.com

Displaying 1 - 20 of 150

Sort: Relevancy | Date

News Daily News

Meta-analysis Teases Out What Drives Success in M-TEER

Caitlin E. Cox

February 10, 2026

News Daily News

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

Caitlin E. Cox

August 13, 2025

Presentation NY Valves 2025

A Treatment Algorithm for GDMT in FMR Patients (Including ‘Dynamic’ MR)

Presenter: JoAnn Lindenfeld

June 25, 2025

Presentation NY Valves 2025

Mitral TEER in Symptomatic FMR: Emerging Data and Futuristic Trends

Presenter: Gregg W. Stone

June 25, 2025

Presentation NY Valves 2025

Optimizing Mitral TEER in FMR: Technical and Device Strategies

Presenter: Jörg Hausleiter

June 25, 2025

Presentation NY Valves 2025

GDMT in FMR: What Every Interventionalist Needs to Know

Presenter: Sean P. Pinney

June 25, 2025

Presentation NY Valves 2025

Phenotyping of FMR: Imaging Classification, Severity Assessment, and Parameters for Futility

Presenter: Federico M. Asch

June 25, 2025

News Conference News THT 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

Todd Neale

February 21, 2025

Presentation THT 2025

Remarkable Simplicity: A Case Review of the Carillon Therapy

Presenter: Scott Lilly

February 12, 2025

Presentation THT 2025

200+ Patients, Real-World Impact: Carillon Therapy in Routine Care

Presenter: Holger Priebe-Brämer

February 12, 2025

Presentation THT 2025

Rethinking MR: A Heart Failure Physician's Perspective

Presenter: Hansie Mathelier

February 12, 2025

Presentation THT 2025

CINCH Registry: 5-Year Evidence of Efficacy and Durability

Presenter: Klaus Witte

February 12, 2025

Presentation THT 2025

Strategies to Reduce the Burden of Residual MACE After mTEER in Patients With FMR

Presenter: Michael Brener

February 12, 2025

Presentation TCT 2024

Characterizing Atrial FMR: From Diagnosis to Management Pathways

Presenter: Rebecca Hahn

October 30, 2024

Presentation TCT 2024

Atrial FMR From a Surgeon’s Perspective: At the Crossroads of Surgical and Transcatheter Intervention

Presenter: Robert Smith

October 29, 2024

Presentation TCT 2024

Atrial FMR From a Structuralist’s Perspective: M-TEER and Beyond

Presenter: Stephan Baldus

October 29, 2024

Presentation TCT 2024

Atrial FMR Primer: Epidemiology, Pathophysiology, Imaging Features, and Clinical Presentation

Presenter: Federico Asch

October 29, 2024

Presentation TCT 2024

Medical and Atrial Fibrillation Management for Atrial FMR

Presenter: Gabriel Sayer

October 29, 2024

Presentation TCT 2024

M-TEER for Moderate to Severe FMR in Symptomatic Heart Failure: Comparison of RESHAPE-HF2 Trial Results With Outcomes in MITRA-FR and COAPT

Presenter: Stefan Anker

October 27, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2024

Shelley Wood

October 01, 2024

Advertisement

Meta-analysis Teases Out What Drives Success in M-TEER

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

A Treatment Algorithm for GDMT in FMR Patients (Including ‘Dynamic’ MR)

Mitral TEER in Symptomatic FMR: Emerging Data and Futuristic Trends

Optimizing Mitral TEER in FMR: Technical and Device Strategies

GDMT in FMR: What Every Interventionalist Needs to Know

Phenotyping of FMR: Imaging Classification, Severity Assessment, and Parameters for Futility

Positive Results With Carillon Mitral Device Seen in Real-world Registries

Remarkable Simplicity: A Case Review of the Carillon Therapy

200+ Patients, Real-World Impact: Carillon Therapy in Routine Care

Rethinking MR: A Heart Failure Physician's Perspective

CINCH Registry: 5-Year Evidence of Efficacy and Durability

Strategies to Reduce the Burden of Residual MACE After mTEER in Patients With FMR

Characterizing Atrial FMR: From Diagnosis to Management Pathways

Atrial FMR From a Surgeon’s Perspective: At the Crossroads of Surgical and Transcatheter Intervention

Atrial FMR From a Structuralist’s Perspective: M-TEER and Beyond

Atrial FMR Primer: Epidemiology, Pathophysiology, Imaging Features, and Clinical Presentation

Medical and Atrial Fibrillation Management for Atrial FMR

M-TEER for Moderate to Severe FMR in Symptomatic Heart Failure: Comparison of RESHAPE-HF2 Trial Results With Outcomes in MITRA-FR and COAPT

TCTMD’s Top 10 Most Popular Stories for September 2024

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content